Factors Affecting Survival Time of Cholangiocarcinoma Patients: A Prospective Study in Northeast Thailand

  • Woradet, Somkiattiyos (Department of Epidemiology, Faculty of Public Health, Khon Kaen University) ;
  • Promthet, Supannee (Department of Epidemiology, Faculty of Public Health, Khon Kaen University) ;
  • Songserm, Nopparat (Department of Community Health, Faculty of Public Health, Ubon Ratchathani Rajabhat University) ;
  • Parkin, Donald Maxwell (Clinical Trial Service Unit & Epidemiological Studies Unit, University of Oxford)
  • 발행 : 2013.03.30


Cholangiocarcinoma (CCA) is a major health problem and cause of death among people in Northeastern Thailand. In this prospective study 171 patients newly diagnosed with CCA by physicians in 5 tertiary hospitals in four provinces of northeastern of Thailand between February and July 2011 were followed up to January 2012. The outcome was survival time from diagnosis to death. A total of 758.4 person-months of follow-up were available. The mortality rate was 16.9 per 100 person-months (95%CI: 14.1-20.1). The median survival time among CCA patients was 4.3 months (95%CI: 3.3-5.1). Cox's proportional hazard model was used to study the independent effects of factors affecting survival time among patients. Statistically significant factors included advanced stage at diagnosis (HR: 2.5, 95%CI: 1.7-3.8), presentation with jaundice (HR: 1.7, 95%CI: 1.1-2.4) or ascites (HR: 2.8, 95%CI: 1.8-4.4), and positive serum carcinoembryonic antigen (HR: 2.3, 95%CI: 1.2-4.3). Patients who had received standard treatment had a better prognosis that those who did not (HR: 0.5, 95%CI: 0.3-0.7).


  1. Blechacz B, Gores GJ (2008). Cholangiocarcinoma: advances in pathogenesis, diagnosis, and treatment. Hepatology, 48, 308-21.
  2. Bunsiripaiboon P, Sornmayura P, Wilasrusmee C, Lertsithichai P (2010). The prognostic significance of microvessel density in intrahepatic cholangiocarcinoma. J Med Assoc Thai, 93, 66-72.
  3. Cheng Q, Luo X, Zhang B, et al (2007). Predictive factors for prognosis of hilar cholangiocarcinoma: postresection radiotherapy improves survival. Eur J Surg Oncol, 33, 202-7.
  4. Cho SY, Park SJ, Kim SH, et al (2010). Survival analysis of intrahepatic cholangiocarcinoma after resection. Ann Surg Oncol, 17, 1823-30.
  5. Ferlay J, Shin HR, Bray F, et al (2010). Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer, 127, 2893-917.
  6. Guglielmi A, Ruzzenente A, Campagnaro T, et al (2009). Intrahepatic cholangiocarcinoma: prognostic factors after surgical resection. World J Surg, 33, 1247-54.
  7. Hamidi M, Moody JS, Kozak KR (2010). Refusal of radiation therapy and its associated impact on survival. Am J Clin Oncol, 33, 629-32.
  8. Hasegawa S, Ikai I, Fujii H, Hatano E, Shimahara Y (2007). Surgical resection of hilar cholangiocarcinoma: analysis of survival and postoperative complications. World J Surg, 31, 1256-63.
  9. Kamsa-ard S, Wiangnon S, Suwanrungruang K, et al (2011). Trends in liver cancer incidence between 1985 and 2009, Khon Kaen, Thailand: cholangiocarcinoma. Asian Pac J Cancer Prev, 12, 2209-13.
  10. Knuppel M, Kubicka S, Vogel A, et al (2012). Combination of conservative and interventional therapy strategies for intra- and extrahepatic cholangiocellular carcinoma: a retrospective survival analysis. Gastroenterol Res Pract, 19, 7-8.
  11. Li H, Qin Y, Cui Y, et al (2011). Analysis of the surgical outcome and prognostic factors for hilar cholangiocarcinoma: a Chinese experience. Dig Surg, 28, 226-31.
  12. Mihalache F, Tantau M, Diaconu B, Acalovschi M (2010). Survival and quality of life of cholangiocarcinoma patients:a prospective study over a 4 year period. J Gastrointestin Liver Dis, 19, 285-90.
  13. Murakami Y, Uemura K, Sudo T, et al (2011). Prognostic factors after surgical resection for intrahepatic, hilar, and distal cholangiocarcinoma. Ann Surg Oncol, 18, 651-8.
  14. Nakagohri T, Kinoshita T, Konishi M, Takahashi S, Gotohda N (2008). Surgical outcome and prognostic factors in intrahepatic cholangiocarcinoma. World J Surg, 32, 2675-80.
  15. Nuzzo G, Giuliante F, Ardito F, et al (2010). Intrahepatic cholangiocarcinoma: prognostic factors after liver resection. Updates Surg, 62, 11-9.
  16. Park J, Kim MH, Kim KP, et al (2009). Natural history and prognostic factors of advanced cholangiocarcinoma without surgery, chemotherapy, or radiotherapy: a large-scale observational study. Gut Liver, 3, 298-305.
  17. Parkin DM, Ohshima H, Srivatanakul P, Vatanasapt V (1993). Cholangiocarcinoma: epidemiology, mechanisms of carcinogenesis and prevention. Cancer Epidemiol Biomarkers Prev, 2, 537-44.
  18. Pattanathien P, Khuntikeo N, Promthet S, Kamsa-ard S (2013). Survival rate of extrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev, 14, 321-4.
  19. Sriamporn S, Black RJ, Sankaranarayanan R, et al (1995). Cancer survival in Khon Kaen Province, Thailand. Int J Cancer, 61, 296-300.
  20. Sriplung H, Sontipong S, Martin N, et al (2005). Cancer incidence in Thailand, 1995-1997. Asian Pac J Cancer Prev, 6, 276-81.
  21. Sriputtha S, Khuntikeo N, Promthet S, Kamsa-ard S (2013) Survival rate of intrahepatic cholangiocarcinoma patients after surgical treatment in Thailand. Asian Pac J Cancer Prev, 14, 1107-10.
  22. Vatanasapt V, Martin N, Sriplung H, et al (1995). Cancer incidence in Thailand, 1988-1991. Cancer Epidemiol Biomarkers Prev, 4, 475-83.
  23. Vatanasapt V, Tangvoraphonkchai V, Titapant V, et al (1990). A high incidence of liver cancer in Khon Kaen province, Thailand. Southeast Asian J Trop Med Public Hlth, 21, 489-94.
  24. Verkooijen HM, Fioretta GM, Rapiti E, et al (2005). Patients' refusal of surgery strongly impairs breast cancer survival. Ann Surg, 242, 276-80.
  25. Yun YH, Lee MK, Park SM, et al (2012). Effect of complementary and alternative medicine on the survival and health-related quality of life among terminally ill cancer patients: a prospective cohort study. Ann Oncol, 24, 489-94.
  26. Yusoff AR, Razak MM, Yoong BK, Vijeyasingam R, Siti ZM (2012). Survival analysis of cholangiocarcinoma: a 10-year experience in Malaysia. World J Gastroenterol, 18, 458-65.

피인용 문헌

  1. Analysis of Different Ways of Drainage for Obstructive Jaundice Caused by Hilar Cholangiocarcinoma vol.15, pp.14, 2014,
  2. Survival Analysis of Biliary Tract Cancer Cases in Turkey vol.15, pp.15, 2014,
  3. Health-Related Quality of Life and Survival of Cholangiocarcinoma Patients in Northeastern Region of Thailand vol.11, pp.9, 2016,
  4. High expression of apoptosis-inducing factor, mitochondrion-associated 3 (AIFM3) in human cholangiocarcinoma vol.37, pp.10, 2016,
  5. Evaluating a preoperative protocol that includes magnetic resonance imaging for lymph node metastasis in the Cholangiocarcinoma Screening and Care Program (CASCAP) in Thailand vol.15, pp.1, 2017,
  6. A significant cancer burden and high mortality of intrahepatic cholangiocarcinoma in Thailand: a nationwide database study vol.17, pp.1, 2017,